These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
647 related articles for article (PubMed ID: 14960647)
1. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647 [TBL] [Abstract][Full Text] [Related]
2. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635 [TBL] [Abstract][Full Text] [Related]
3. 18F-fluoride PET/CT for bone scanning. Role of attenuation correction. Nagarajah J; Dannat T; Hartung V; Bockisch A; Rosenbaum-Krumme S Nuklearmedizin; 2012; 51(3):84-7. PubMed ID: 22366817 [TBL] [Abstract][Full Text] [Related]
4. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin. Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438 [TBL] [Abstract][Full Text] [Related]
5. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Metser U; Even-Sapir E Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153 [TBL] [Abstract][Full Text] [Related]
6. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas. Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420 [TBL] [Abstract][Full Text] [Related]
7. The role of PET/CT in evaluation of Facet and Disc abnormalities in patients with low back pain using (18)F-Fluoride. Gamie S; El-Maghraby T Nucl Med Rev Cent East Eur; 2008; 11(1):17-21. PubMed ID: 19173183 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282 [TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma. Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607 [TBL] [Abstract][Full Text] [Related]
10. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy. Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343 [TBL] [Abstract][Full Text] [Related]
11. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. Israel O; Yefremov N; Bar-Shalom R; Kagana O; Frenkel A; Keidar Z; Fischer D J Nucl Med; 2005 May; 46(5):758-62. PubMed ID: 15872347 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology. Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380 [TBL] [Abstract][Full Text] [Related]
13. Detection of metastatic bone lesions in breast cancer patients: fused (18)F-Fluoride-PET/MDCT has higher accuracy than MDCT. Preliminary experience. Piccardo A; Altrinetti V; Bacigalupo L; Puntoni M; Biscaldi E; Gozza A; Cabria M; Iacozzi M; Pasa A; Morbelli S; Villavecchia G; DeCensi A Eur J Radiol; 2012 Oct; 81(10):2632-8. PubMed ID: 22227259 [TBL] [Abstract][Full Text] [Related]
14. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer. Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354 [TBL] [Abstract][Full Text] [Related]
16. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI. Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Ghanem N; Uhl M; Brink I; Schäfer O; Kelly T; Moser E; Langer M Eur J Radiol; 2005 Jul; 55(1):41-55. PubMed ID: 15950100 [TBL] [Abstract][Full Text] [Related]
18. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. Du Y; Cullum I; Illidge TM; Ell PJ J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153 [TBL] [Abstract][Full Text] [Related]